Cargando…
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People
While CD8+ T cells specific for human cytomegalovirus (HCMV) have been extensively studied in both healthy HCMV seropositive carriers and patients undergoing immunosuppression, studies on the CD4+ T cell response to HCMV had lagged behind. However, over the last few years there has been a significan...
Autores principales: | Lim, Eleanor Y., Jackson, Sarah E., Wills, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248300/ https://www.ncbi.nlm.nih.gov/pubmed/32509591 http://dx.doi.org/10.3389/fcimb.2020.00202 |
Ejemplares similares
-
Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay
por: Houldcroft, Charlotte J., et al.
Publicado: (2020) -
Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells
por: Renzaho, Angelique, et al.
Publicado: (2020) -
Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response
por: Forte, Eleonora, et al.
Publicado: (2020) -
QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
por: Pongsakornkullachart, Kritsada, et al.
Publicado: (2022) -
Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts
por: Ji, Shengwei, et al.
Publicado: (2022)